Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer

Unlocking Innovations: Stay Current with the Latest in Ovarian Cancer Management UpdatesПодробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?Подробнее

KCRS24 Session Four: Ongoing Clinical Trials in Kidney Cancer/ Trials in Progress | KidneyCANПодробнее

Identifying optimal patient subgroups in ovarian cancer for neoadjuvant PARP inhibitor therapyПодробнее

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Redefining Endometrial and Ovarian Carcinoma CareПодробнее

Recurrent Ovarian Cancer (2023)Подробнее

Decoding Cancer Clinical Trials | Medical Case Discussion | Assimilate by MedvarsityПодробнее

Smilow Shares: Breast Cancer Education Series (CME) - Treatment Advances/Clinical TrialsПодробнее

What are my options after PARP inhibitor and immunotherapy?Подробнее

Innovative and Emerging Trials in Ovarian CancerПодробнее

Ep2 : Is Immunotherapy Replacing Chemo in the First-Line Treatment Setting for Endometrial Cancer?Подробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

New & Novel Clinical Trials in Ovarian CancerПодробнее

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancerПодробнее

Recurrent Ovarian Cancer - Questions and Answers (2022)Подробнее

Ovarian Cancer Treatments, Research and Survivorship Updates 2022Подробнее

Recurrent Ovarian Cancer (2022)Подробнее

Research: Ovarian Cancer Canada’s current progress and forward momentumПодробнее